Mainz Biomed (MYNZ) News Today → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free MYNZ Stock Alerts $0.90 +0.03 (+3.46%) (As of 04/24/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMainz Biomed N.V. (MYNZ) Price Target Decreased by 9.09% to 5.10msn.com - April 17 at 2:35 AMThe Pharmaceutical Industry Finds Itself At A Historical Crossroadsfinance.yahoo.com - April 10 at 1:44 PMMYNZ Stock Earnings: Mainz Biomed Beats EPS, Misses Revenue for Q4 2023investorplace.com - April 9 at 11:01 PMEQS-News: Mainz Biomed Reports Full Year 2023 Financial Resultsmarkets.businessinsider.com - April 9 at 1:06 PMMainz Biomed Reports Full Year 2023 Financial Resultsglobenewswire.com - April 9 at 8:01 AMMYNZ Mainz Biomed N.V.seekingalpha.com - April 5 at 6:13 PMPharma's Post-Pandemic Story To Unlock A Cancer-Free Erabenzinga.com - April 2 at 12:37 PMEQS-News: Mainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatmentmarkets.businessinsider.com - March 19 at 9:00 AMMainz Biomed Organizes HALLO DOC! Event to Highlight Innovations in Colorectal Cancer Treatmentglobenewswire.com - March 19 at 8:01 AMEQS-News: Mainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Optionsmarkets.businessinsider.com - March 18 at 12:56 PMMainz Biomed: Webinar on Early Detection of Colorectal Cancer - Exploring New Laboratory Diagnostic Optionsglobenewswire.com - March 18 at 8:01 AMMainz BioMed NV: Mainz Biomed Presents ColoAlert at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovationsfinanznachrichten.de - March 12 at 8:41 AMMainz Biomed Presents ColoAlert® at UDH Congress 2024: Leading the Way in Evidence-Based Cancer Screening Innovationsglobenewswire.com - March 12 at 8:01 AMMainz Biomed Partners with Trusted Health Advisors to Support U.S. Go-To-Market Strategy for Next Generation Early Colorectal Cancer Diagnosticglobenewswire.com - March 5 at 8:01 AMEQS-News: Mainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Communitymarkets.businessinsider.com - February 27 at 7:49 PMMainz Biomed to Showcase at the Gynecology Conference in Stuttgart, Germany, Strengthening Connections within the Medical Communityglobenewswire.com - February 27 at 8:01 AMEQS-News: Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®markets.businessinsider.com - February 22 at 8:08 PMMainz BioMed NV: Mainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlertfinanznachrichten.de - February 22 at 3:08 PMMainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®finance.yahoo.com - February 22 at 10:08 AMMainz Biomed Announces Distribution Partnership with Praxisdienst for ColoAlert®globenewswire.com - February 22 at 8:01 AMEQS-News: Mainz BioMed N.V.: Mainz Biomed geht strategische Partnerschaft mit TomaLab zur Ausweitung der Verfügbarkeit von ColoAlert® in Italien einfinanznachrichten.de - February 21 at 5:32 PMMainz BioMed NV: Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert in Italyfinanznachrichten.de - February 21 at 12:31 PMEQS-News: Mainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italymarkets.businessinsider.com - February 21 at 12:31 PMMainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italyfinance.yahoo.com - February 21 at 12:31 PMMainz Biomed Establishes Strategic Partnership with TomaLab to Expand Availability of ColoAlert® in Italyglobenewswire.com - February 21 at 8:01 AMMainz Biomed Establishes Physician-Led Laboratory Expanding Service Offering for Privately Insured Patients in Germanyfinance.yahoo.com - February 6 at 8:59 AM2 Million Cancer Diagnoses And 600,000 Cancer Deaths Expected In 2024 – Prevention Is Key To Treatment, And Mainz Biomed Is Leading The Chargebenzinga.com - February 1 at 12:09 PMMainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdansk Gastroenterology Symposiumtmcnet.com - January 11 at 1:04 PMMainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposiumfinance.yahoo.com - January 11 at 1:04 PM2024 Marks a New Era Of Pharmaceutical Innovationbenzinga.com - January 9 at 2:57 PMEQS-News: Mainz Biomed Provides Year-End Corporate Review 2023markets.businessinsider.com - January 9 at 9:56 AMMainz Biomed Provides Year-End Corporate Review 2023finance.yahoo.com - January 9 at 9:56 AMMainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employeesfinance.yahoo.com - December 19 at 8:44 AMMainz Biomed NV MYNZmorningstar.com - December 12 at 7:34 PMEQS-News: Mainz BioMed N.V.: Mainz Biomed präsentiert ColoAlert® auf zwei führenden Gastroenterologie-Konferenzen in Polenfinanznachrichten.de - December 12 at 9:34 AMEQS-News: Mainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Polandmarkets.businessinsider.com - December 12 at 9:34 AMMainz Biomed Showcases ColoAlert® at Two Prominent Gastroenterology Conferences in Polandfinance.yahoo.com - December 12 at 9:34 AMEQS-News: Mainz BioMed N.V.: Mainz Biomed meldet positive Topline-Ergebnisse der US-Studie eAArly DETECT mit neuartigen mRNA-Biomarkernfinanznachrichten.de - December 6 at 10:12 AMMainz Biomed B.V.: Buy Rating with High CRC Detection Success and AI Integrationmarkets.businessinsider.com - December 6 at 10:12 AMMainz Biomed Reports Positive Topline Results from U.S. eAArly DETECT Study Evaluating Novel mRNA Biomarkersfinance.yahoo.com - December 5 at 12:52 PMMainz Biomed N.V. (MYNZ)uk.finance.yahoo.com - December 2 at 10:07 AMMainz Biomed's Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcasttmcnet.com - November 29 at 12:35 PMMainz Biomed’s Presentation at the 35th Annual Piper Sandler Healthcare Conference to be Made Available via Webcastfinance.yahoo.com - November 29 at 12:35 PMCantor Fitzgerald cuts Mainz to neutral, cites liquidity concernsmsn.com - November 21 at 7:57 PMEQS-News: Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conferencemarkets.businessinsider.com - November 20 at 8:24 AMThe Latest Analyst Ratings for Mainz Biomedmarkets.businessinsider.com - November 20 at 8:24 AMMainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conferencefinance.yahoo.com - November 20 at 8:24 AMEQS-News: Mainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Updatemarkets.businessinsider.com - November 16 at 8:42 AMMainz Biomed Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 16 at 8:42 AMMainz Biomed Announces Closing of $5.0 million Registered Direct Offeringfinance.yahoo.com - November 15 at 9:12 AM Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address The A.I. story nobody is telling you (Read ASAP) (Ad)There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about... Click here to see Louis' new video for yourself. MYNZ Media Mentions By Week MYNZ Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MYNZ News Sentiment▼0.000.44▲Average Medical News Sentiment MYNZ News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MYNZ Articles This Week▼02▲MYNZ Articles Average Week Get Mainz Biomed News Delivered to You Automatically Sign up to receive the latest news and ratings for MYNZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Context Therapeutics News Grifols News LAVA Therapeutics News NLS Pharmaceutics News Pharvaris News Procaps Group News Qilian International Holding Group News Tiziana Life Sciences News Aclarion News Alpha Tau Medical News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MYNZ) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority Gold Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mainz Biomed Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
